SANTA ANA, Calif.--(BUSINESS WIRE)--Advanced Medical Optics, Inc. (AMO) (NYSE:EYE) today announced the pricing of a private offering of $250 million aggregate principal amount of its 7.50% senior subordinated notes due 2017. The notes were offered only to qualified institutional buyers and non-U.S. foreign investors in accordance with Rule 144A and Regulation S, respectively, under the Securities Act of 1933. The sale of the notes is conditioned upon and will be consummated substantially concurrent with the closing of the merger with IntraLase Corp. (IntraLase).
